Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Zante Greg
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
Avg. Two Year Performance
No purchase track record
50%
Avg. Sale Return
22%
Compound
1 Mo
3 Mo
6 Mo
1 Yr
2 Yr
Average Purchase Return
--
--
--
--
--
Purchase Success Rate
--
--
--
--
--
Average Sale Return
16%
15%
13%
3%
50%
Sale Success Rate
7 of 7
4 of 7
6 of 7
6 of 7
5 of 7
Viking Therapeutics, Inc.
Drugs
» Biotechnology
Chief Financial Officer:
Holdings:
187.05K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--
Sangamo Biosciences Inc.
Drugs
» Biotechnology
VP, Finance & Administration:
Holdings:
0.69K
shares
Sentiment
Avg. Two Year Performance
No purchase track record
No sale track record
Last Three Months:
0
Net Amount
Buy:
0
--
Sell:
0
--